0001564590-20-018686.txt : 20200427 0001564590-20-018686.hdr.sgml : 20200427 20200427080338 ACCESSION NUMBER: 0001564590-20-018686 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200424 ITEM INFORMATION: Other Events FILED AS OF DATE: 20200427 DATE AS OF CHANGE: 20200427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 20817293 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 8-K 1 hznp-8k_20200424.htm 8-K hznp-8k_20200424.DOCX.htm
false Horizon Therapeutics Public Ltd Co 0001492426 00-0000000 0001492426 2020-04-24 2020-04-24

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2020

 

Horizon Therapeutics Public Limited Company

(Exact name of registrant as specified in its charter)

 

Ireland

(State or other jurisdiction

of incorporation)

001-35238

(Commission

File No.)

Not Applicable

(IRS Employer

Identification No.)

 

 

 

Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland

(Address of principal executive offices)

 

 

 

Registrant’s telephone number, including area code: 011-353-1-772-2100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Ordinary shares, nominal
value $0.0001 per share

HZNP

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

 

 

 

 

 

Item 8.01

Other Events.

 

On April 24, 2020, a subsidiary of Horizon Therapeutics plc (“Horizon”) entered into an agreement with S.R. One, Limited (“S.R. One”) pursuant to which Horizon acquired all of S.R. One’s beneficial rights to proceeds from certain contingent future TEPEZZA (teprotumumab-trbw) milestone and royalty payments in exchange for a one-time payment of $55.0 million.  

 

In May 2017, Horizon acquired River Vision Development Corp. (“River Vision”) and in connection with the acquisition, the previously outstanding capital stock of River Vision was converted into an up-front cash payment and rights to receive contingent future milestone and royalty payments related to TEPEZZA. The remaining aggregate potential milestone payments are $225 million and are payable based on certain TEPEZZA worldwide net sales thresholds being achieved as noted in the following table:  

 

 

TEPEZZA Worldwide Net Sales Threshold

Milestone

Payment

>$250 million

$50 million

>$375 million

$75 million

>$500 million

$100 million


In addition, Horizon is obligated to pay a 3% royalty on the portion of annual worldwide net sales of TEPEZZA exceeding $300.0 million (such royalty, together with the milestone payments the “TEPEZZA Payments”).  S.R. One, as one of the former River Vision stockholders, held rights to receive approximately 35.66% of any future TEPEZZA Payments.  As a result of the transaction with S.R. One, Horizon’s remaining net obligations to make TEPEZZA Payments to the former stockholders of River Vision will be reduced by approximately 35.66%.

 

 

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 27, 2020

 

 

 

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

 

 

 

 

 

 

 

 

By:

 

/s/ Paul W. Hoelscher

 

 

 

 

 

 

Paul W. Hoelscher

 

 

 

 

 

 

Executive Vice President, Chief Financial Officer

 

 

 

 

 EX-101.SCH 2 hznp-20200424.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 hznp-20200424_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, Address Line Three Entity Address Address Line3 Entity Address, City or Town Entity Address City Or Town Entity Address, Country Entity Address Country Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 4 hznp-20200424_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE JSON 7 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hznp-8k_20200424.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "hznp-8k_20200424.htm" ] }, "labelLink": { "local": [ "hznp-20200424_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hznp-20200424_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hznp-20200424.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hznp", "nsuri": "http://www.horizonoharma.com/20200424", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "hznp-8k_20200424.htm", "contextRef": "C_0001492426_20200424_20200424", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "hznp-8k_20200424.htm", "contextRef": "C_0001492426_20200424_20200424", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address Address Line3", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "verboseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information
Apr. 24, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 24, 2020
Entity Registrant Name Horizon Therapeutics Public Ltd Co
Entity Central Index Key 0001492426
Entity Emerging Growth Company false
Entity File Number 001-35238
Entity Incorporation State Country Code L2
Entity Tax Identification Number 00-0000000
Entity Address, Address Line One Connaught House
Entity Address, Address Line Two 1st Floor
Entity Address, Address Line Three 1 Burlington Road
Entity Address, City or Town Dublin 4
Entity Address, Country IE
Entity Address, Postal Zip Code D04 C5Y6
City Area Code 011-353-1
Local Phone Number 772-2100
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Ordinary shares, nominal value $0.0001 per share
Trading Symbol HZNP
Security Exchange Name NASDAQ
XML 11 hznp-8k_20200424_htm.xml IDEA: XBRL DOCUMENT 0001492426 2020-04-24 2020-04-24 false Horizon Therapeutics Public Ltd Co 0001492426 00-0000000 8-K 2020-04-24 L2 001-35238 Connaught House 1st Floor 1 Burlington Road Dublin 4 D04 C5Y6 IE 011-353-1 772-2100 false false false false Ordinary shares, nominal value $0.0001 per share HZNP NASDAQ false ZIP 12 0001564590-20-018686-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-018686-xbrl.zip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end XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.horizonoharma.com/20200424/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports hznp-8k_20200424.htm hznp-20200424.xsd hznp-20200424_lab.xml hznp-20200424_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end